Astrana Health (ASTH) Cash & Current Investments (2010 - 2026)

Astrana Health (ASTH) has 17 years of Cash & Current Investments data on file, last reported at $478.4 million in Q1 2026.

• Quarterly Cash & Current Investments rose 83.35% year-over-year to $478.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $478.4 million (up 83.35% YoY) and the FY2025 annual result came in at $429.5 million, up 47.67% from the prior year.
• Cash & Current Investments advanced to $478.4 million in Q1 2026 per ASTH's latest filing, from $429.5 million in the prior quarter.
• The five-year high for Cash & Current Investments was $478.4 million in Q1 2026, with the low at $217.3 million in Q3 2022.
• Average Cash & Current Investments over 5 years is $323.3 million, with a median of $296.3 million recorded in 2023.
• Year-over-year, Cash & Current Investments sank 34.81% in 2022 and soared 83.35% in 2026.
• Astrana Health's Cash & Current Investments stood at $293.6 million in 2022, then increased by 0.92% to $296.3 million in 2023, then retreated by 1.85% to $290.8 million in 2024, then surged by 47.67% to $429.5 million in 2025, then grew by 11.39% to $478.4 million in 2026.
• Business Quant data shows ASTH's Cash & Current Investments at $478.4 million in Q1 2026, $429.5 million in Q4 2025, and $463.4 million in Q3 2025.